STOCK TITAN

Board member at cbdMD (YCBD) granted 1,572 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stephen Scott G. reported acquisition or exercise transactions in this Form 4 filing.

cbdMD, Inc. director Stephen Scott G. received a grant of 1,572 restricted stock units as compensation for serving on the Board of Directors. Each unit represents one share of common stock and will vest in four quarterly installments on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this award, he holds 4,412 shares of common stock directly.

Positive

  • None.

Negative

  • None.
Insider Stephen Scott G.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 1,572 $0.00 --
Holdings After Transaction: Common Stock — 4,412 shares (Direct)
Footnotes (1)
  1. [object Object]
RSU grant size 1,572 units Restricted stock units granted to director as Board compensation
Shares held after grant 4,412 shares Total common stock holdings following the RSU award
Vesting dates June 30, 2026; Sept 30, 2026; Dec 31, 2026; Mar 31, 2027 Quarterly vesting schedule for restricted stock units
restricted stock units financial
"Represents restricted stock units. Each restricted stock unit represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16(b) regulatory
"The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3 regulatory
"by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Equity Compensation Plan financial
"issued under the 2021 or 2025 Equity Compensation Plan as compensation"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stephen Scott G.

(Last)(First)(Middle)
2101 WESTINGHOUSE BLVD. SUITE A

(Street)
CHARLOTTE NORTH CAROLINA 28273

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
cbdMD, Inc. [ YCBD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)04/14/2026A1,572A$04,412D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
/s/ Scott Stephen04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did cbdMD (YCBD) report for Stephen Scott G.?

cbdMD reported that director Stephen Scott G. received 1,572 restricted stock units as a stock-based compensation award. Each unit equals one share of common stock, granted for his service on the Board of Directors under the company’s equity compensation plan.

Is the cbdMD (YCBD) Form 4 transaction a stock purchase or a grant?

The Form 4 transaction is a stock grant, not a market purchase. Stephen Scott G. was awarded 1,572 restricted stock units at no cash cost as part of his director compensation package, approved by the company’s Compensation, Corporate Governance and Nominating Committee.

How do the 1,572 cbdMD (YCBD) restricted stock units vest?

The 1,572 restricted stock units vest in four quarterly installments. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, giving the director contingent rights to receive shares over this period, subject to plan terms.

How many cbdMD (YCBD) shares does Stephen Scott G. hold after this grant?

After the grant, Stephen Scott G. holds 4,412 shares of cbdMD common stock directly. This total includes the newly awarded 1,572 restricted stock units, which represent contingent rights to receive an equivalent number of common shares as they vest over time.

Under which plan were the cbdMD (YCBD) restricted stock units granted?

The restricted stock units were issued under cbdMD’s 2021 or 2025 Equity Compensation Plan. These plans authorize stock-based awards as compensation, and the grant to director Stephen Scott G. was made for his Board service under the plan’s established terms.

Was the cbdMD (YCBD) stock grant exempt from Section 16(b) short-swing rules?

Yes. The grant was described as exempt from Section 16(b) under Rule 16b-3. This exemption applies because the award was approved in advance by cbdMD’s Compensation, Corporate Governance and Nominating Committee, which consists entirely of non-employee directors.